Search the Newsreel

IM Cannabis Posts Deeper Losses and Negative Equity in Second Quarter 2026

IM Cannabis Corp. (IMCC) Stock Falls on Q2 2026 Earnings

IM Cannabis Corp. (IMCC) reported a significant decline in Q2 2026 revenue, down 42.8% year-over-year to $5.4 million, with a net loss of $3.1 million. This financial performance led to a 1.9% drop in the stock price after market close. Institutional investors showed mixed …

IM Cannabis Revenue Falls to C$16.3M as Half-Year Loss Widens

IM Cannabis (Nasdaq: IMCC) revenue drops as losses mount and going concern risk cited

IM Cannabis Corp. (IMCC) reported a significant revenue drop and mounting losses for the first half of 2026, leading management to flag substantial doubt about the company's ability to continue as a going concern. Revenue fell to $16.268 million from $25.196 million year-over-year, with …

IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results

IM Cannabis Corp. (IMC) announced its financial results for the second quarter and first half of 2026, reporting a decrease in revenue and an increased net loss compared to the same periods in 2025. For the first half of 2026, revenue was $16.3 million …

IM Cannabis closes $250,000 convertible note financing

IM Cannabis Corp. (NASDAQ:IMCC) has completed a $250,000 convertible note financing through a private placement with an institutional investor. The note carries an 8% annual interest rate, convertible into common shares at a specified price, and includes warrants to purchase additional common shares. The …

IM Cannabis (Nasdaq: IMCC) raises $250K in convertible note financing

IM Cannabis Corp. (Nasdaq: IMCC) has secured US$250,000 in convertible note financing from an institutional investor, issuing a note and a warrant for up to 2,052,545 common shares. The company received net proceeds of US$225,000, which will be used for general corporate purposes. The …

IM Cannabis Corp (IMCC) Earnings Forecast: Future EPS & Revenue Growth Estimates

IM Cannabis Corp. announced that it has received $0.225 million in funding

IM Cannabis Corp. announced that it has received $0.225 million in funding, as reported on August 6, 2026. The company also raised $250,000 through convertible note financing on August 7, 2026, and expects to receive another $0.225 million in funding. IM Cannabis Corp. is …

IM Cannabis Corp (IMCC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of IM Cannabis Corp (IMCC), detailing its current price momentum score of 5.69 and noting its stock price is trading between support at $0.09 and resistance at $0.15. It includes a summary of various technical indicators (MACD, RSI, …

IM Cannabis Corp (IMCC) Institutional Confidence

This article focuses on the institutional confidence score for IM Cannabis Corp (IMCC) as of July 29, 2026. It presents a list of key shareholders and their holdings, including notable changes for Heron Bay Capital Management, LLC and BMO Nesbitt Burns Inc. The overall …

IM Cannabis Says Alon Dayan Resigned for Personal Reasons

IM Cannabis (Nasdaq: IMCC) announced that director Alon Dayan resigned from its board for personal reasons. The company's board and management thanked him for his contributions. IM Cannabis operates a medical cannabis platform in Israel and Germany, and its stock saw a mild positive …

IM Cannabis Provides Corporate Update

IM Cannabis Corp. (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announced the resignation of Mr. Alon Dayan from its board of directors due to personal reasons. The company expressed gratitude for his contributions and wished him well. IM Cannabis …

IM Cannabis director Alon Dayan resigns from board By Investing.com

IM Cannabis Corp. announced that director Alon Dayan has resigned from its board for personal reasons. The medical cannabis company, which operates in Israel and Germany, has not yet named a replacement. The company thanked Dayan for his service and is evaluating expansion opportunities …

IM Cannabis (Nasdaq: IMCC) discloses board resignation and corporate update

IM Cannabis Corp. announced the resignation of director Alon Dayan, effective July 26, 2026, citing personal reasons unrelated to company policies. The company, which operates a medical cannabis platform in Israel and Germany, also provided a corporate update on its operations, including importing, distributing, …

TradingKey

This page provides a detailed quarterly and annual balance sheet analysis for IM Cannabis Corp (IMCC), allowing users to evaluate its financial health through various key metrics. It includes data spanning from FY2012Q1 to FY2026Q1 for assets, liabilities, and shareholders' equity, along with definitions …

Price to sales forward of IM Cannabis Corp. – BOATS:IMCC

This article presents the "Price to sales forward" metric for IM Cannabis Corp. (IMCC) on the Blue Ocean Alternative Trade System (BOATS) through TradingView. It indicates that the market was closed at the time of publication and provides no specific value for the metric, …

IMCC|IM Cannabis Corp|Price:0.121|Chg%:-0.012

IM Cannabis Corp (IMCC) shares closed at $0.121, down 9.17%, with a market cap of $752.40K. The company operates in the medical cannabis sector in Israel and Germany, showing significant growth potential despite recent stock market performance and being considered overvalued with a PE …

IM Cannabis Corp. Revenue Breakdown – NASDAQ:IMCC

IM Cannabis Corp. (NASDAQ:IMCC) reported that its largest revenue contribution came from Germany, accounting for $26.01 million USD in the last year, a significant increase from $11.32 million USD the prior year. This financial breakdown highlights the company's regional performance and dependence on the …

Enterprise value to EBIT forward of IM Cannabis Corp. – NASDAQ:IMCC

This article provides a financial snapshot for IM Cannabis Corp. (NASDAQ:IMCC), specifically focusing on its enterprise value to EBIT forward. It indicates that the NASDAQ market was closed with no trades at the time of publication, presenting financial data and general information about the …